Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMMNCs in Retinitis Pigmentosa
NCT01914913Phase 2Unknown
- Sponsor
- Chaitanya Hospital
- Start
- Sep 2014
- Primary completion
- Nov 2016
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of bone marrow mononuclear cells in retinitis pigmentosa (RP), sponsored by Chaitanya Hospital. Status: unknown.
02
Drugs
bone marrow mononuclear cells
03
Conditions
retinitis pigmentosa (RP)
Beyond the preview
Go deeper on NCT01914913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01914913.